KOENIG SHELDON L. (Chief Operating Officer) sold 3.2% of their position (48.24K shares) of ESPERION THERAPEUTICS, INC. on the open market
Open‑market sale worth $177.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2025ACC: 0001628280-25-057944
Officer· Chief Operating Officer
Since Dec 2020
-48.24K
Net shares
Net seller
$177.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
48.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−48.24K
Price / share
$3.67
Trade value
$177.20K
% of position
3.2%
12/17/2025
1.52M→1.47M
Total
Net shares
−48.24K
Net value
-$177.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2025 | S · Sale | −48.24K | $3.67 | $177.20K | 3.2% | 1.52M | 1.47M |
| Total | −48.24K | -$177.20K | ||||||
Derivative Transactions0
No derivative transactions reported